EGENESIS INC has a total of 15 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets biotechnology, agriculture and medical technology are TRANSGENIC INC, JIANGSU JICUI YAOKANG BIOTECHNOLOGY CO LTD and HWANG WOO SUK.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | Singapore | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Agriculture | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Animal care | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Yang Luhan | 13 |
#2 | Qin Wenning | 5 |
#3 | Gao Yangbin | 5 |
#4 | Kan Yinan | 5 |
#5 | Guell Marc | 5 |
#6 | Luhan Yang | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020228810A1 | Cells, tissues, organs, and/or animals having one or more modified genes for enhanced xenograft survival and/or tolerance | |
WO2021072778A1 | Cells, tissues, organs, and/or animals having one or more modified genes for enhanced xenograft survival and/or tolerance | |
WO2021072777A1 | Cells, tissues, organs, and/or animals having one or more modified genes for enhanced xenograft survival and/or tolerance | |
WO2020228043A1 | Cells, tissues, organs, and/or animals having one or more modified genes for enhanced xenograft survival and/or tolerance | |
WO2020228039A1 | Cells, tissues, organs, and/or animals having one or more modified genes for enhanced xenograft survival and/or tolerance | |
CA3060630A1 | Methods for generating genetically modified animals |